EXAS vs PRGS · rev $2.76B vs P/E 16, rev $501.3M
EXACT Sciences Corporation (EXAS) versus Progress Software Corporation (PRGS) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Progress Software Corporation (PRGS) is a software - infrastructure company listed on US.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Latest reported PRGS revenue for 2026-05-31 was $501.3M. Net income was $43.9M. PRGS currently screens at market cap $1.33B and trailing P/E 16.2.
EXAS currently screens at market cap $20.03B. PRGS currently screens at market cap $1.33B and trailing P/E 16.2.
Not investment advice. Open the EXAS and PRGS stock pages for the full models.
Not investment advice.